
New data on RevMed’s Rasonque leave potential opening for other treatments
<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxQcGZTdndsM1NpRW9ZTGRHSVJweFNvTDRTd1lMbGdpUUF1V29MNWN6OFVtV0pzenk5SWFrZG9YdFAyeVFJN1pWdXVkSlZzbElLZDQzSHJwSG1PWUg5RnY0Y2VvT0NFdldpVWUtZUgwdGJ2ZFh6UU9weW1mWFI0TWlkVnVPZmlnRl9DbVhaaFBJT1ZuTjVQUTctMmQtb1A1Zw?oc=5" target="_blank">New data on RevMed’s Rasonque leave potential opening for other treatments</a>&nbsp;&nbsp;<font color="#6f6f6f">Endpoints News</font>
